|
Market Closed -
Nasdaq
16:00:00 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 3.010 USD | -7.10% |
|
-36.50% | -80.73% |
Company Valuation: Tonix Pharmaceuticals Holding Corp.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 177.4 | 22.42 | 23.62 | 61.64 | 193.6 | 58.49 | - | - |
| Change | - | -87.36% | 5.35% | 160.94% | 214.02% | -69.78% | - | - |
| Enterprise Value (EV) | 177.4 | 22.42 | 23.62 | 61.64 | 193.6 | 58.49 | 58.49 | 58.49 |
| Change | - | -87.36% | 5.35% | 160.94% | 214.02% | -69.78% | 0% | 0% |
| P/E | -1.38x | -0.12x | -0.06x | -0.19x | -1.07x | -0.28x | -0.49x | -0.89x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | 0x | 0x | 0x | 0x |
| Capitalization / Revenue | - | - | 3.04x | 6.11x | 14.8x | 1.02x | 0.52x | 0.31x |
| EV / Revenue | - | - | 0x | 0x | 0x | 1.02x | 0.52x | 0.31x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.32x | -0.34x | -0.47x |
| EV / FCF | - | - | - | - | - | -0.3x | -0.31x | -0.41x |
| FCF Yield | - | - | - | - | - | -333% | -327% | -245% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -166,400 | -65,400 | -21,920 | -176.6 | -14.57 | -10.86 | -6.178 | -3.37 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | 7.768 | 10.09 | 13.11 | 57.51 | 112.8 | 185.8 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -92.31 | -112.1 | -118.4 | -136.7 | -125.7 | -182.8 | -172.9 | -123.7 |
| Net income 1 | -92.29 | -116.9 | -116.7 | -130 | -124 | -185.1 | -164.5 | -114.8 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 228,928.000 | 7,796.000 | 1,289.600 | 32.980 | 15.620 | 3.010 | 3.010 | 3.010 |
| Nbr of stocks (in thousands) | 0.78 | 2.88 | 18.3 | 1,869 | 12,392 | 19,432 | - | - |
| Announcement Date | 3/14/22 | 3/13/23 | 4/1/24 | 3/18/25 | 3/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.3x | - | - | - | 62.96M | |
| 41.92x | 14.14x | 29.98x | 0.48% | 1,271B | |
| 41.5x | 6.96x | 19.58x | 1.88% | 683B | |
| 37.54x | 8.61x | 17.78x | 2.34% | 520B | |
| 21.85x | 5.3x | 13.27x | 2.47% | 389B | |
| 104.3x | 5.95x | 25.36x | 2.31% | 362B | |
| 24.13x | 5.85x | 14.24x | 2.72% | 304B | |
| 24.18x | 4.84x | 13.59x | 1.81% | 286B | |
| 24.11x | 7.4x | 13.59x | 2.16% | 253B | |
| -39.46x | 7.31x | 46.04x | 1.97% | 208B | |
| Average | 27.98x | 7.37x | 21.49x | 2.01% | 428B | |
| Weighted average by Cap. | 37.31x | 8.88x | 22.52x | 1.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- TNXP Stock
- Valuation Tonix Pharmaceuticals Holding Corp.
Select your edition
All financial news and data tailored to specific country editions
